Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Apogee Therapeutics logo

Apogee Therapeutics

Recent Finacing

Series B

Recent Raise

$149M

Apogee Therapeutics is a San Francisco biotechnology company developing a pipeline of therapeutics targeting immunological and inflammatory disorders, advancing APG777 toward clinical trials and following validated development pathways.

Founded 2022
California, United States
101-250
Publicly Traded
apogeetherapeutics.com

Highlights

Focus Areas

Biotechnology
Life Science
Medical
Therapeutics

Recent Investors

RTW Investments logo
Deep Track Capital logo

Financials

$149M

Total Raised

1

Funding round

2

Investors


Team

Upgrade to view the team

See the team members at Apogee Therapeutics.